Журнал Современные проблемы науки и образования

2070-7428

Общество с ограниченной ответственностью "Издательский Дом "Академия Естествознания"

ART-14498

РОЛЬ ЛИМФАДЕНЭКТОМИИ В ХИРУРГИЧЕСКОМ ЛЕЧЕНИИ РАКА ТЕЛА МАТКИ И РАКА ЯИЧНИКОВ

Яйцев

С.В.

Yaytsev

S.V.

jaitsev@yandex.ru

Асабаева

Р.И.

Asabaeva

R.I.

r.assabaeva@mail.ru

Шаназаров

Н.А.

Shanazarov

N.A.

nasrulla@inbox.ru

ГБОУ ВПО «Южно-Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации South Ural State Medical University

09 05 2014

5 451 451

This is an open-access article distributed under the terms of the CC BY 4.0 license.

https://science-education.ru/ru/article/view?id=14498

Проведен анализ современной литературы по эффективности лимфаденэктомии при раке тела матки и раке яичников. Известно, что наличие метастазов в лимфатических узлах является одним из наиболее важных прогностических факторов для рака эндометрия и рака яичников, но подход к оценке лимфатических узлов остается одним из самых спорных вопросов в диагностике и лечении рака этой локализации. В настоящее время эффективность и объем лимфаденэктомии как при раке эндометрия, так и при раке яичников многими исследователями ставятся под сомнение, а ее принятие в качестве рутинной процедуры зависит от страны. Хотя большинство онкогинекологов согласны с пользой лимфаденэктомии у больных с распространенными стадиями заболевания и даже при ранних стадиях заболевания в группе больных с высоким риском, широко обсуждается вопрос о необходимости поиска более оптимального хирургического лечения больных раком эндометрия и раком яичников.

The analysis of the current literature on the effectiveness of lymphadenectomy in cancer of the corpus uteri and ovarian cancer. It is known that the presence of lymph node metastasis is one of the most important prognostic factors for endometrial cancer and ovarian cancer, but the approach to the assessment of lymph nodes is one of the most controversial issues in the diagnosis and treatment of cancer of this localization. Currently, the efficiency and scope of lymphadenectomy as endometrial cancer and ovarian cancer many researchers have been questioned, and its adoption as a routine procedure depends on the country. Although most cancers agree with the use of lymphadenectomy in patients with advanced stages of the disease, and even in the early stages of the disease in patients with high risk, widely discussed the need to find a more optimal surgical treatment of patients with endometrial cancer and ovarian cancer.

рак тела матки рак яичников лимфаденэктомия

uterine cancer ovarian cancer lymphadenectomy

1. Кузнецов В.В., Нечушкина В.М. Хирургическое лечение рака тела матки // Практическая онкология. – 2004. – Т. 5. – № 1. – С. 25-32.

2. Покатаев И.А. Активная хирургическая тактика в современном алгоритме лечения распространенного рака яичника // Совр. онкол. – 2010. – Т. 12. – № 4. – С. 32-34.

3. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer // Obstet. Gynecol. – 2005. – Vol. 106. – P. 413-425.

4. ASTEC study group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study // Lancet. – 2009. – Vol. 373. – P. 125-136.

5. Ballester M. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO) // Lancet Oncol. – 2011. – Vol. 12. – P. 469-476.

6. Bell M.C. Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques // Gynecol. Oncol. – 2008. – Dec. Vol. 111. – N. 3. – P. 407-411.

7. Benedetti P.P. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial // J. Natl. Cancer Inst. – 2008. – Vol. 100. – P. 1707-1716.

8. Boronow R.C. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study // Obstet. Gynecol. – 1984. – Vol. 63. – P. 825-832.

9. Case A.S. A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer // Obstet. Gynecol. – 2006. – Vol. 108. – P. 1375-1379.

10. Chang S.J., Bristow R.E. Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: Redefining ‘optimal’ residual disease // Gynecol. Oncol. – 2012. – Vol. 125. – P. 483-492.

11. Convery P.A. Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma // Gynecol. Oncol. – 2011. – Vol. 123. – P. 65-70.

12. Creasman W.T. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study // Cancer. – 1987. – Oct – Vol. 15. – N. 60 (suppl. 8). – P. 2035-2041.

13. Creasman W. Revised FIGO staging for carcinoma of the endometrium // Int. J. Gynaecol. Obstet. – May 2009. – Vol. 105. – N. 2. – P. 109.

14. Creasman W.T., Mutch D.E., Herzog T.J. ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? // Gynecol. Oncol. – 2010. – Vol. 116. – P. 293-294.

15. Dowdy S.C. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer // Gynecol. Oncol. – 2012. – Vol. 127. – P. 5-10.

16. du Bois A. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO) // Cancer. – 2009. – Vol. 115. – P. 1234-1244.

17. Fader A.N. Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: A multi-site study performed at high volume cancer centers // Gynecol. Oncol. – 2012. – Vol. 126. – P. 180-185.

18. Fotopoulou C. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identifi cation of predictive factors for lymph-node status // Eur. J. Obstet. Gynecol. Reprod. Biol. – 2010. – Vol. 149. – P. 199-203.

19. Franchi M. Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer // J. Surg. Oncol. – 2001. – Dec. – Vol. 78. – N. 4. – P. 232-237.

20. Frederick P.J., Straughn J.M. The role of comprehensive surgical staging in patients with endometrial cancer // Cancer Control. – 2009. – Vol. 16. – P. 23-29.

21. Hacker N.F. Primary cytoreductive surgery for epithelial ovarian cancer // Obstet. Gynecol. – 1983. – Vol. 61. – P. 413-420.

22. Harter P. Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer // Int. J. Gynecol. Cancer. – 2007. – Vol. 17: 1238-1244

23. Jeong N.H. Role of systematic lymphadenectomy and adjuvant radiation in early-stage endometrioid uterine cancer // Ann. Surg. Oncol. – 2010. – Vol. 17. – P. 2951-2957.

24. Kehoe S.M., Miller D.S. The role of lymphadenectomy in endometrial cancer // Clin. Obstet. Gynecol. – 2011. – Vol. 54. – P. 235-244.

25. Khoury-Collado F. Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed? // Gynecol. Oncol. – 2009. – Vol. 115. – P. 453-455.

26. Khoury-Collado F.M. Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes // Gynecol. Oncol. – 2011. – Vol. 122. – P. 251-254.

27. Kitchener H. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. ASTEC study group // Lancet. – 2009. – Vol. 373. – P. 125-136.

28. Kumar S. Second neoplasms in survivors of endometrial cancer: impact of radiation therapy // Gynecol. Oncol. – 2009. May. – Vol. 113. – N. 2. – P. 233-239. Epub 2009. Feb 26.

29. Kumar S. A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer // Gynecol. Oncol. – 2012. – Vol. 127. – P. 525-531.

30. Leitao Jr. Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma // Gynecol. Oncol. – Nov 2008. – Vol. 111. – N. 2. – P. 244-248.

31. Lewin S.N. Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer // Obstet. Gynecol. – 2010. – Vol. 116. – P. 1141-1149.

32. Lowery W.J. Surgical staging for endometrial cancer in the elderly - Is there a role for lymphadenectomy? // Gynecol. Oncol. – 2012. – Vol. 126. – P. 12-15.

33. Mais V. Intraoperative lymphatic mapping techniques for endometrial cancer // Expert. Rev. Anticancer Ther. – 2010. – Vol. 11. – P. 83-93.

34. Mariani A. Stage IIIC endometrioid corpus cancer includes distinct subgroups // Gynecol. Oncol. – 2002. – Vol. 87. – P. 112-117.

35. Mariani A. Surgical stage I endometrial cancer: predictors of distant failure and death // Gynecol. Oncol. – 2002. – Vol. 87. – P. 274-280.

36. May K. Lymphadenectomy for the management of endometrial cancer // Cochrane Database Syst. Rev. – 2010. – Vol. 1: CD007585

37. McMeekin D.S. What should lymphadenectomy offer in early-stage endometrial cancer: lots of variables, little control // Am. J. Obstet. Gynecol. – 2011. – Vol. 205. – P. 509-510.

38. Meigs J.V. Tumors of the female pelvic organs. New York: Macmillan, 1934.

39. Morice P. Lymph node involvement in epithelial ovarian cancer: Analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications // J. Am. Coll. Surg. – 2003. – Vol. 197. – P. 198-205.

40. Mourits M.J. Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomized trial // Lancet Oncol. – 2010. – Vol. 11. – N. 8. – P. 763-771.

41. Nout R.A. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial // Lancet. 2010. – Vol. 375. – P. 816-823.

42. Panici B.R. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomized clinical trial // J. Natl. Cancer Inst. – 2005. – Vol. 97. – P. 560-566.

43. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium // Int. J. Gynaecol. Obstet. – 2009. – Vol. 105. – N. 2. – P. 103-104.

44. Peiretti M. Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: surgical and oncological outcomes. Single institution experience // Gynecol. Oncol. – 2010. – Vol. 119. – P. 259-264.

45. Spirtos N.M. Cytoreductive surgery in advanced epithelial ovarian cancer of the ovary: The impact of aortic and pelvic lymphadenectomy // Gynecol. Oncol. – 1995. – Vol. 56. – P. 345-352.

46. Todo Y. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis // Lancet. – 2010. – Vol. 375. – P. 1165-1172.

47. Trovik J. Improved survival related to changes in endometrial cancer treatment, a 30-year population based perspective // Gynecol. Oncol. – 2012. – Vol. 125. – P. 381-387.

48. Wimberger P. Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group) // Ann. Surg. Oncol. – 2010. – Vol. 17. – P. 1642-1648.

49. Wright J.D. Contemporary management of endometrial cancer // Lancet. – 2012. – Vol. 379. – P. 1352-1360.

50. Yoo H.J. Transabdominal cardiophrenic lymph node dissection (CPLND) via incised diaphragm replace conventional video-assisted thoracic surgery for cytoreductive surgery in advanced ovarian cancer // Gynecol. Oncol. – 2013. – Vol. 129. – P. 341-345.